NCCN Guidelines Insights: Kidney cancer, version 1.2021 Guidelines

  


Authors: Motzer, R. J.; Jonasch, E.; Boyle, S.; Carlo, M. I.; Manley, B.; Agarwal, N.; Alva, A.; Beckermann, K.; Choueiri, T. K.; Costello, B. A.; Derweesh, I. H.; Desai, A.; George, S.; Gore, J. L.; Haas, N.; Hancock, S. L.; Kyriakopoulos, C.; Lam, E. T.; Lau, C.; Lewis, B.; Madoff, D. C.; McCreery, B.; Michaelson, M. D.; Mortazavi, A.; Nandagopal, L.; Pierorazio, P. M.; Plimack, E. R.; Ponsky, L.; Ramalingam, S.; Shuch, B.; Smith, Z. L.; Somer, B.; Sosman, J.; Dwyer, M. A.; Motter, A. D.
Title: NCCN Guidelines Insights: Kidney cancer, version 1.2021
Abstract: The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to certain systemic therapy recommendations for patients with relapsed or stage IV RCC. They also discuss the addition of a new section to the guidelines that identifies and describes the most common hereditary RCC syndromes and provides recommendations for genetic testing, surveillance, and/or treatment options for patients who are suspected or confirmed to have one of these syndromes.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 18
Issue: 9
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2020-09-01
Start Page: 1160
End Page: 1170
Language: English
DOI: 10.6004/jnccn.2020.0043
PUBMED: 32886895
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090506174&doi=10.6004%2fjnccn.2020.0043&partnerID=40&md5=81a1204df1bd6491a630532533bbc246
Notes: Article -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer
  2. Maria Isabel Carlo
    162 Carlo
Related MSK Work